Artificial Intelligence for the Identification of Endometrial Malignancies

Aim of this article is to investigate the potential of Artificial Intelligence (AI) in the discrimination between benign and malignant endometrial nuclei and lesions. For this purpose, 416 histologically confirmed liquid-based cytological smears were collected and morphometric characteristics of cell nuclei were measured via image analysis. Then, 50% of the cases were used to train an AI system, specifically a learning vector quantization (LVQ) neural network. As a result, cell nuclei were classified as benign or malignant. Data from the remaining 50% of the cases were used to evaluate the AI system performance. By nucleic classification, an algorithm for the classification of individual patients was constructed, and performance indices on patient classification were calculated. The sensitivity for the classification of nuclei was 77.95%, and the specificity was 73.93%. For the classification of individual patients, the sensitivity was 90.70% and the specificity 82.79%. These results indicate that an AI system can have an important role in endometrial lesions classification.